Active Ingredient(s): Triethanolamine Polypeptide Oleate Condensate
FDA Approved: * June 25, 1958
Category: Ear Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cerumenex Overview

TEOA is listed under Schedule 3, part B of the Chemical Weapons Convention as it can be used in the manufacture of HN3 nitrogen mustard. See also Complexometric titration Ethanolamine Ethanol Triethanolamine salicylate References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-c...

Read more Cerumenex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Triethanolamine

Recent Cerumenex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Triethanolamine Polypeptide Oleate Condensate
  • Solution: 10%
  • Solution/drops: 10%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Triethanolamine Polypeptide Oleate Condensate or a similar ingredient: (1 result)